Jabil Inc. has completed the acquisition of Pharmaceutics International, Inc. (Pii), a CDMO specialising in aseptic filling, lyophilization, and oral solid dose manufacturing. The transaction, finalised on February 3, 2025, enhances Jabil’s presence in pharmaceutical development and manufacturing. With this
Pharmaceutics International Inc. (Pii), a contract development and manufacturing organization (CDMO), has announced a $3.6 million investment to enhance its prefilled syringe (PFS) capabilities. This move is aimed at improving efficiency and regulatory compliance for pharmaceutical and biotech companies in
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
